The G-BA Innovation Committee published funding priorities in Germany

03

Aug 2022

On June 27, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for healthcare research projects (seven topics) and clinical guidelines (four topics).

The following funding priorities were defined for healthcare research projects:

  • Health in climate change;
  • Digitization and networking of quality-assured guideline knowledge and further development of the methodology;
  • Health services research to improve the situation of affected people when it comes to the provision of medical aids;
  • Improvement of specialist medical and dental care in inpatient care facilities;
  • Prerequisites for the development and requirements for the implementation of eHealth in patient care;
  • Health services research on aftercare and discharge management;
  • Drug therapy: implications of switching from best supportive care (BSC) or off-label use (OLU) to indication-specific approved drugs.

The deadline for submitting ideas is October 25, 2022, at noon.

The funding priorities for clinical guidelines include:

  • Care for more frequent diseases with a cross-sectoral need for coordination;
  • Care for target groups with special needs (e.g., children, young people, elderly and/or people in need of care, gender-specific characteristics, people with disabilities, ethical aspects);
  • The health of the population/public health (e.g., health promotion, prevention through lifestyle modification, protective measures, health communication);
  • Intensive care of critically ill patients.

The deadline for submitting ideas is September 27, 2022, at noon.

Applications can only be submitted in electronic form via the internet portal of the project sponsor responsible for handling the funding measures, the German Aerospace Center (Deutsches Zentrum für Luft- und Raumfahrt; DLR).

The full details in German can be found here, here (healthcare research projects: topic-specific funding announcement), here (healthcare research projects: open-topic funding announcement), and here (funding announcement for clinical guidelines).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

12

Aug 2022

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on using new and existing health technologies, likely to significantly impact healthcare. In July 2022, SHTG published three reports (KardiaMobile for detecting atrial fibrillation, complex endovascular aneurysm repair, and Togetherall platform). Currently, the SHTG is working on assessments of technologies in the field of cancer, radiotherapy, musculoskeletal diseases, transplantation, and other topics.

Read more

11

Aug 2022

The French National Authority for Health released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies in July 2022. Twenty recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services. Opinions concern cardiovascular and peripheral vascular, neurovascular and neuromodulation, orthopedic, endocrine, and ENT devices, as well as breast implants and medical aids. Except for this, CNEDiMTS published two positive and two negative opinions concerning transitional coverage of devices.

Read more

10

Aug 2022

In July 2022, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (transcatheter tricuspid valve annuloplasty for tricuspid regurgitation, and transcatheter tricuspid valve leaflet repair for tricuspid regurgitation), one new Diagnostic Guidance (PLGF-based testing to help diagnose suspected preterm pre-eclampsia), and four new Medtech Innovation Briefings (ProciseDx point-of-care platform for IBD, RespiraSense for continuously monitoring respiratory rate, Lenus COPD Support Service, and cyanoacrylate glue for hernia mesh fixation). Also, five clinical guidelines were updated.

Read more

09

Aug 2022

In May-July 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers.

Read more

08

Aug 2022

In July 2022, the Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) published on its website five Digi-HTAs in the fields of eHealth and in-vitro diagnostics.

Read more